Skip to main content

Table 5 Attitudes to risk-reducing medicationa

From: Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice

Statement

Very much agree n (%)

Somewhat agree n (%)

Somewhat disagree n (%)

Very much disagree n (%)

The side-effects of these medicines may affect my decision to take medicine (n = 236)

133 (56)

50 (21)

20 (8)

33 (14)

Other people’s experiences with it (n = 224)

68 (30)

60 (27)

45 (21)

51 (23)

That is also used as a cancer medicine (n = 224)

37 (17)

41 (18)

62 (28)

84 (38)

It is a reminder of your breast cancer risk (n = 227)

25 (11)

23 (10)

44 (19)

135 (60)

  1. aIncludes only women who have not had a risk-reducing mastectomy